Beta
221039

Nigella sativa L. as a potential natural product for the treatment of COVID-19

Article

Last updated: 01 Jan 2025

Subjects

-

Tags

Pharmaceutical Chemistry

Abstract

The world is now facing a public health emergency caused by the coronavirus pandemic (COVID-19). The World Health Organization (WHO) has called it an emerging pandemic due to its sudden appearance and distribution. Coronavirus disease 2019 (COVID-19) is a pandemic caused by the Coronavirus2 of the Extreme Acute Respiratory Syndrome (SARS-CoV2). Nigella sativa (N. sativa) (Family Ranunculaceae) is a globally used medicinal herb. Unani and Tibb, Ayurveda, and Siddha are only a few of the western medical systems that use it. N. sativa, also known as black seed, is an essential medicinal plant that has long been used as a multipurpose medicinal agent in various countries. Immune deficiency, autophagy deficiency, oxidative stress, pathological inflammation, diabetes, cardiovascular diseases, and bacterial and viral infections are all treated effectively with the essential oil and other preparations of the N. sativa crop. It comprises of many essential groups of bioactive compounds, one of which, thymoquinone, has piqued the scientific community's interest due to its active function in treating a wide variety of diseases. The therapeutic effectiveness of N. sativa, as well as recent computational results, clearly suggest that it may be used to tackle the COVID-19 pandemic that has recently arisen. The aim of this review is to highlight the therapeutic importance of N. sativa in conventional medicine, as well as the potential for its use as an antiviral agent against the SARS-CoV2 virus and for further preclinical research.

DOI

10.21608/ejchem.2022.111517.5069

Keywords

COVID-19, SARS-COV2, Nigella Sativa, natural products, World health organization, pandemic

Authors

First Name

Khaldun

Last Name

Al Azzam

MiddleName

-

Affiliation

Pharmacological and Diagnostic Research Center (PDRC), Department of Pharmaceutical Sciences, Faculty of Pharmacy, Al-Ahliyya Amman University, Amman 19328, Jordan

Email

azzamkha@yahoo.com

City

Amman

Orcid

0000-0003-4097-6991

First Name

Rima

Last Name

Al Omari

MiddleName

Mohammad

Affiliation

Pharmacological and Diagnostic Research Center (PDRC), Department of Pharmaceutical Sciences, Faculty of Pharmacy, Al-Ahliyya Amman University, Amman 19328, Jordan

Email

r.alomari@ammanu.edu.jo

City

Amman

Orcid

0000-0002-4661-656X

First Name

Adam

Last Name

aburoub

MiddleName

-

Affiliation

Pharmacological and Diagnostic Research Center (PDRC), Department of Pharmaceutical Sciences, Faculty of Pharmacy, Al-Ahliyya Amman University, Amman 19328, Jordan

Email

a.aburoub@ammanu.edu.jo

City

Amman

Orcid

-

First Name

Lyazzat

Last Name

Bekbayeva

MiddleName

-

Affiliation

Biology Program, School of Distance Education, Universiti Sains Malaysia, Penang, Malaysia

Email

lyazzat_bk2019@mail.ru

City

Almaty

Orcid

0000-0002-0804-1259

First Name

El-Sayed

Last Name

Negim

MiddleName

Moussa

Affiliation

Laboratory of Advanced Materials and Technology, Kazakh-British Technical University, 59 Tole bi St., 050000, Almaty, Kazakhstan

Email

elashmawi5@yahoo.com

City

Almaty

Orcid

0000-0002-4370-8995

First Name

Hassan

Last Name

aboulenein

MiddleName

-

Affiliation

Pharmaceutical and Medicinal Chemistry Department, National Research Centre, Dokki, Giza 12311, Egypt

Email

haboulenein@yahoo.com

City

cairo

Orcid

0000-0003-0249-7009

Volume

65

Article Issue

10

Related Issue

34864

Issue Date

2022-10-01

Receive Date

2021-12-16

Publish Date

2022-10-01

Page Start

141

Page End

151

Print ISSN

0449-2285

Online ISSN

2357-0245

Link

https://ejchem.journals.ekb.eg/article_221039.html

Detail API

https://ejchem.journals.ekb.eg/service?article_code=221039

Order

13

Type

Review Articles

Type Code

444

Publication Type

Journal

Publication Title

Egyptian Journal of Chemistry

Publication Link

https://ejchem.journals.ekb.eg/

MainTitle

Nigella sativa L. as a potential natural product for the treatment of COVID-19

Details

Type

Article

Created At

22 Jan 2023